Bond.az White LogoBond.az Black Logo
→
EN ▾
AZENRU
Secrets to Tanning Without Damaging SkinFrench woman marries manga characterBloating Cause: Alcohol Consumption'Smart bear' closes schools in JapanMonkey kills child in ThailandDancing aurora in space capturedHidden danger: vacuum cleaner health riskRetro wave: 60s accessory back in trendIran sends harsh message to US: "We don't trust you"Nesta Appointed Head Coach of AvellinoSecrets to Tanning Without Damaging SkinFrench woman marries manga characterBloating Cause: Alcohol Consumption'Smart bear' closes schools in JapanMonkey kills child in ThailandDancing aurora in space capturedHidden danger: vacuum cleaner health riskRetro wave: 60s accessory back in trendIran sends harsh message to US: "We don't trust you"Nesta Appointed Head Coach of Avellino
Personalize
Bond.az White LogoBond.az Black Logo
AZENRU
TRANSCRIPTS

Cinclus Pharma Q1 2026 Revenue Milestone Boosts Stock

Cinclus Pharma Q1 2026 earnings: first revenue of SEK 10 million, stock up 4.08%. New partnerships and financing boost confidence.

Sophia Anderson
BySophia Anderson- Senior Editor
|
0
Cinclus Pharma Q1 2026 Revenue Milestone Boosts Stock
Photo: Prepared by Bond.az

Cinclus Pharma reported its first-ever revenue in Q1 2026, reaching SEK 10 million. New partnerships in Europe and China drove this milestone.

The company's stock rose 4.08% pre-market, reflecting cautious investor optimism.

Strategic financing from Claret Capital Partners extends the runway through Q3 2027.

Focus remains on linaprazan glurate and the HEEALING 1 trial, with top-line results expected in Q4 2026.

More News
RHI Magnesita India Q4 2026 Revenue Milestone
2026-05-30 12:34
|
261

RHI Magnesita India Q4 2026 Revenue Milestone

RHI Magnesita India hits revenue milestone in Q4 2026 with 9% revenue growth. Stock declines. Detailed analysis on Bond.az.

TRANSCRIPTS →
0
Zomedica Q1 2026 sees record revenue growth
2026-05-29 22:02
|
415

Zomedica Q1 2026 sees record revenue growth

Zomedica Q1 2026 revenue hits record $8.8M, up 35% YoY. TRUFORMA adoption drives diagnostics growth. PIMS integration set for Sept 2026. Targets profitability by 2027.

TRANSCRIPTS →
0
QT Imaging Revenue Surges 133% in Q1 2026
2026-05-29 13:00
|
807

QT Imaging Revenue Surges 133% in Q1 2026

QT Imaging Holdings Q1 2026 revenue surged 133% to $6.5M, but net loss and earnings miss led to an 11.59% stock drop.

TRANSCRIPTS →
0
NEXT Biometrics Strategic Pivot Amid Q1 Challenges
2026-05-29 07:32
|
682

NEXT Biometrics Strategic Pivot Amid Q1 Challenges

NEXT Biometrics shifts to IP licensing in Q1 2026 amid revenue decline and strategic transformation. Stock rises 6.06%.

TRANSCRIPTS →
0
Elastic Q4 2026 Beats Expectations, Stock Rises
2026-05-28 22:32
|
439

Elastic Q4 2026 Beats Expectations, Stock Rises

Elastic Q4 2026 beats EPS and revenue expectations, stock jumps 6.72% after hours. Forward guidance highlights AI-driven growth.

TRANSCRIPTS →
0
Autodesk Q1 2027 beats expectations, stock dips
2026-05-28 22:31
|
965

Autodesk Q1 2027 beats expectations, stock dips

Autodesk Q1 2027 EPS and revenue beat estimates. New transaction model and MaintainX acquisition support future growth.

TRANSCRIPTS →
0
Park Aerospace Q4 2026 revenue grows
2026-05-28 22:30
|
524

Park Aerospace Q4 2026 revenue grows

Park Aerospace Q4 2026 revenue growth and strategic outlook.

TRANSCRIPTS →
0
PagerDuty Q1 2027 Earnings Beat Expectations, Stock Up
2026-05-28 22:02
|
713

PagerDuty Q1 2027 Earnings Beat Expectations, Stock Up

PagerDuty Q1 2027 earnings beat expectations with EPS of $0.32 vs $0.25 forecast. Revenue hit $121M. Stock rose 1.53% after hours. Company transitions to usage-based pricing.

TRANSCRIPTS →
0
HealthEquity Q1 2027 beats forecasts with strong EPS
2026-05-28 22:01
|
985

HealthEquity Q1 2027 beats forecasts with strong EPS

HealthEquity Q1 2027 EPS $1.24 beats $1.11 forecast; revenue $354.6M tops estimates. Stock up 4.56%.

TRANSCRIPTS →
0
U-Haul Q4 2026 earnings miss estimates
2026-05-28 16:06
|
614

U-Haul Q4 2026 earnings miss estimates

U-Haul Q4 2026 earnings miss estimates due to fleet depreciation. Stock falls 1.5%. Company plans $560M CapEx reduction and $350M buyback.

TRANSCRIPTS →
0
Build-A-Bear Q1 2026: EPS beats, revenue misses
2026-05-28 14:31
|
906

Build-A-Bear Q1 2026: EPS beats, revenue misses

Build-A-Bear Q1 2026 results: EPS beats forecast, revenue misses. Stock falls 2.65%. Full-year guidance revised lower.

TRANSCRIPTS →
0
Xunlei Q1 2026: Revenue Soars, Stock Climbs
2026-05-28 13:30
|
242

Xunlei Q1 2026: Revenue Soars, Stock Climbs

Xunlei's Q1 2026 revenue surged 54% to $98.6 million. Stock price climbed to $5.95.

TRANSCRIPTS →
0
...